相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanomedicine and graphene-based materials: advanced technologies for potential treatments of diseases in the developing nervous system
Giada Cellot et al.
PEDIATRIC RESEARCH (2022)
Visceral leishmaniasis masquerading as drug-induced pancytopenia in myasthenia gravis
Uttam Kumar Nath et al.
DRUG DISCOVERIES AND THERAPEUTICS (2021)
Epidemiology of Myasthenia Gravis in Sweden 2006-2016
Elisabet Westerberg et al.
BRAIN AND BEHAVIOR (2020)
Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study
Saiju Jacob et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
James F. Howard et al.
NEUROLOGY (2019)
Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis
Josep Gamez et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities
Aziz Eftekhari et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
A nationwide epidemiological study of myasthenia gravis in Latvia
A. Zieda et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Chinese Herbal Medicine for Myasthenia Gravis: A Systematic Review and Meta-Analysis
Shuang Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis
Liang Wang et al.
JOURNAL OF NEUROLOGY (2017)
Incidence of Autoimmune Myasthenia Gravis in a Health Maintenance Organization in Buenos Aires, Argentina
Mariela Bettini et al.
NEUROEPIDEMIOLOGY (2017)
Using the STROBE statement to assess reporting in blindness prevalence surveys in low and middle income countries
Jacqueline Ramke et al.
PLOS ONE (2017)
Therapeutic Plasma Exchange in a rare case myasthenic crisis after Botox injection
Azita Chegini
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Incidence and Prevalence of Myasthenia Gravis in Korea: A Population-Based Study Using the National Health Insurance Claims Database
Su-Yeon Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2016)
Study of the prevalence of familial autoimmune myasthenia gravis in a Spanish cohort
Maria Salvado et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Myasthenia gravis: subgroup classifications
Hai-Feng Li et al.
LANCET NEUROLOGY (2016)
EFFICACY OF PREDNISONE FOR THE TREATMENT OF OCULAR MYASTHENIA (EPITOME): A RANDOMIZED, CONTROLLED TRIAL
Michael Benatar et al.
MUSCLE & NERVE (2016)
Prevalence of neuromuscular disorders in Qena governorate/Egypt: population-based survey
Eman M. Khedr et al.
NEUROLOGICAL RESEARCH (2016)
International consensus guidance for management of myasthenia gravis: Executive summary
Donald B. Sanders et al.
NEUROLOGY (2016)
Epidemiology of myasthenia gravis in Ontario, Canada
Ari Breiner et al.
NEUROMUSCULAR DISORDERS (2016)
The Epidemiology of Myasthenia Gravis in Korea
Hyung Seok Lee et al.
YONSEI MEDICAL JOURNAL (2016)
Myasthenia gravis: subgroup classification and therapeutic strategies
Nils Erik Gilhus et al.
LANCET NEUROLOGY (2015)
PREVALENCE AND COST OF MYASTHENIA GRAVIS IN THE MEDICARE BENEFICIARY SAMPLE
B. D. Gordon et al.
VALUE IN HEALTH (2015)
Estimation of incidence, prevalence, and age-at-diagnosis of myasthenia gravis among adults by hospital discharge records
Anett Foldvari et al.
WIENER KLINISCHE WOCHENSCHRIFT (2015)
Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries
J. B. Andersen et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Myasthenia gravis: an update for the clinician
J. P. Sieb
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Nanomedicine Based Nanoparticles for Neurological Disorders
Bhasker Sriramoju et al.
CURRENT MEDICINAL CHEMISTRY (2014)
EFNS/ENS Guidelines for the treatment of ocular myasthenia
E. Kerty et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Diagnostic and clinical classification of autoimmune myasthenia gravis
Sonia Berrih-Aknin et al.
JOURNAL OF AUTOIMMUNITY (2014)
Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis
M. G. Huijbers et al.
JOURNAL OF INTERNAL MEDICINE (2014)
MINIMAL CLINICALLY IMPORTANT DIFFERENCE IN MYASTHENIA GRAVIS: OUTCOMES FROM A RANDOMIZED TRIAL
Hans D. Katzberg et al.
MUSCLE & NERVE (2014)
Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens
Paraskevi Zisimopoulou et al.
AUTOIMMUNITY REVIEWS (2013)
Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4
Jan J. G. M. Verschuuren et al.
AUTOIMMUNITY REVIEWS (2013)
Myasthenia gravis and the neuromuscular junction
Luis Querol et al.
CURRENT OPINION IN NEUROLOGY (2013)
Epidemiological Study of Adult-Onset Myasthenia Gravis in the Area of Belgrade (Serbia) in the Period 1979-2008
D. Lavrnic et al.
NEUROEPIDEMIOLOGY (2013)
Performance of individual items of the quantitative myasthenia gravis score
T. Carolina Barnett et al.
NEUROMUSCULAR DISORDERS (2013)
Myasthenia Gravis in South Trinidad
J Maharaj et al.
WEST INDIAN MEDICAL JOURNAL (2013)
The Myasthenia Gravis-Specific Activities of Daily Living Profile
Srikanth Muppidi
MYASTHENIA GRAVIS AND RELATED DISORDERS I (2012)
Myasthenia and the neuromuscular junction
Nils E. Gilhus
CURRENT OPINION IN NEUROLOGY (2012)
A national epidemiological study of Myasthenia Gravis in Australia
M. Gattellari et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Estimated cost of treating myasthenia gravis in an insured U.S. population
Jeffery T. Guptill et al.
MUSCLE & NERVE (2012)
Predictors of response to immunomodulation in patients with myasthenia gravis
Hans D. Katzberg et al.
MUSCLE & NERVE (2012)
Epidemiology and Geographical Variation of Myasthenia Gravis in the Province of Pavia, Italy
Cristina Montomoli et al.
NEUROEPIDEMIOLOGY (2012)
Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society
Hakan Cetin et al.
WIENER KLINISCHE WOCHENSCHRIFT (2012)
Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Myasthenia Gravis
Osamu Higuchi et al.
ANNALS OF NEUROLOGY (2011)
Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey
Hiroyuki Murai et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
MG-ADL: STILL A RELEVANT OUTCOME MEASURE
Srikanth Muppidi et al.
MUSCLE & NERVE (2011)
Comparison of IVIg and PLEX in patients with myasthenia gravis
D. Barth et al.
NEUROLOGY (2011)
Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992)
D. Lavrnić et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Epidemiology of myasthenia gravis in Norway
Ardis Storm-Mathisen
ACTA NEUROLOGICA SCANDINAVICA (2010)
A systematic review of population based epidemiological studies in Myasthenia Gravis
Aisling S. Carr et al.
BMC NEUROLOGY (2010)
Guidelines for treatment of autoimmune neuromuscular transmission disorders
G. O. Skeie et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
How to write a Cochrane systematic review
Lorna K. Henderson et al.
NEPHROLOGY (2010)
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Kenneth F. Schulz et al.
TRIALS (2010)
Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece
P. Tsiamalos et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Matthew N. Meriggioli et al.
LANCET NEUROLOGY (2009)
SEROPOSITIVE MYASTHENIA GRAVIS: A NATIONWIDE EPIDEMIOLOGIC STUDY
Anne Taraldsen Heldal et al.
NEUROLOGY (2009)
IVIG treatment for myasthenia gravis - Effectiveness, limitations, and novel therapeutic strategies
Lorne Zinman et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin
Philippe Gajdos et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis
Daniel B. Drachman et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
COMPARISON OF OUTCOME MEASURES FROM A TRIAL OF MYCOPHENOLATE MOFETIL IN MYASTHENIA GRAVIS
Gil I. Wolfe et al.
MUSCLE & NERVE (2008)
A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis
NEUROLOGY (2008)
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
D. B. Sanders et al.
NEUROLOGY (2008)
Epidemiology of autoimmune diseases in Denmark
William W. Eaton et al.
JOURNAL OF AUTOIMMUNITY (2007)
Therapeutic options in autoimmune myasthenia gravis
Mario Garcia-Carrasco et al.
AUTOIMMUNITY REVIEWS (2007)
IV immunoglobulin in patients with myasthenia gravis - A randomized controlled trial
Lorne Zinman et al.
NEUROLOGY (2007)
Myasthenia gravis: past, present, and future
Bianca M. Conti-Fine et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Safety of long-term combined immunosuppressive treatment in myasthenia gravis - analysis of adverse effects of 163 patients
C. Rozsa et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Guidelines for the treatment of autoimmune neuromuscular transmission disorders
G. O. Skeie et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
A systematic review of diagnostic studies in myasthenia gravis
Michael Benatar
NEUROMUSCULAR DISORDERS (2006)
Treatment of Myasthenia Gravis exacerbation with intravenous immunoglobulin - A randomized double-blind clinical trial
P Gajdos et al.
ARCHIVES OF NEUROLOGY (2005)
Increasing incidence of late-onset anti-AChR antibody seropositive myasthenia gravis
FE Somnier
NEUROLOGY (2005)
Quantitative myasthenia gravis score: Assessment of responsiveness and longitudinal validity
RS Bedlack et al.
NEUROLOGY (2005)
Epidemiological study of muscular disorders in Assiut, Egypt
HN El-Tallawy et al.
NEUROEPIDEMIOLOGY (2005)
Beneficial Effects of Plasmapheresis before Thymectomy on the Outcome in Myasthenia Gravis
Takeshi Nagayasu et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2005)
Clinical evaluation and management of myasthenia gravis
JC Keesey
MUSCLE & NERVE (2004)
The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland
PW Wirtz et al.
JOURNAL OF NEUROLOGY (2003)
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis
GI Wolfe et al.
MUSCLE & NERVE (2002)
Epidemiology of myasthenia gravis: A population-based study in Stockholm, Sweden
B Kalb et al.
NEUROEPIDEMIOLOGY (2002)
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis
LG De Feo et al.
MUSCLE & NERVE (2002)
Prevalence of myasthenia gravis in Antioquia, Colombia
JL Sánchez et al.
REVISTA DE NEUROLOGIA (2002)
Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis
J Ronager et al.
ARTIFICIAL ORGANS (2001)
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
W Hoch et al.
NATURE MEDICINE (2001)
Mycophenolate mofetil for myasthenia gravis: An open-label pilot study
E Ciafaloni et al.
NEUROLOGY (2001)
Myasthenia gravis on the Dutch antilles: an epidemiological study
H Holtsema et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2000)
Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis
T Sharshar et al.
JOURNAL OF NEUROLOGY (2000)
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK
BK MacDonald et al.
BRAIN (2000)
分享论文
